However, the possible beneficial effects of IGF-I on cortical responses may be altered in pathological situations in which the circulating IGF-I signaling is decreased, such as diabetes or Alzheimer’s disease [2,25]. The gene discussed is IGF1; the disease is Alzheimer disease.